3-D Matrix Home PURAMATRIX CLINICAL APPLICATIONS CLINICAL TRIALS LABORATORY SOLUTIONS COMPANY CONTACT

PuraMatrix® is an ideal synthetic, transparent, biocompatible, and bioresorbable material situated at the intersection of chemical engineering and biology. PuraMatrix® in vivo extracellular matrix has wide-ranging laboratory and clinical applications, including cell culture, drug delivery, accelerated cartilage and bone growth, and regeneration of CNS, soft tissue, and cardiac muscle.




Product Portfolio

PuraStat® Synthetic Surgical Hemostatic Agent
PuraMatrix® Synthetic Peptide Hydrogels
PuraMatrix GMP© Clinical-Grade Gels

In 2004, PuraMatrix® was commercially introduced for use in research applications via Becton Dickinson and is currently sold by Corning, Inc. PuraMatrix® self-assembling peptide-based hydrogel is now available for use in both laboratory and pre-clinical applications, and as CE mark approved clinical surgical hemostatic agent under the trade name PuraStat®.
News Collaborations Publications